View Author
strut stent patient scaffold month follow-up vessel study analysis lesion trial artery change diameter 6 months baseline implantation lumen serruy group bioresorbable device 6- month follow-up imaging result everolimu plaque curvature cohort coherence tomography everolimus-eluting angiographic angulation neointimal segment intravascular signi value difference ultrasound coherence 1.1 figure tomography serruys pw system scaffold area abbott tissue balloon bvs 1.0 lumen area recoil intervention table vessel wall 1.0 12 months restenosi stenosi bvs 1.1 angiography sb ori fice drug-eluting comparison regar e assessment image procedure cardiol ficant polymer malapposed struts increase malapposed generation scaffold pattern irregularities netherland 12- month follow-up reduction
10 Most Recent Publications
|
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography
(Article)
Gomez-Lara, J. Brugaletta, S. Dudek, D. Smits, P.C. Chevalier, B. Regar, E.S. Veldhof, S. Rapoza, R. Ormiston, J.A. Garcia-Garcia, H.M. Serruys, P.W.J.C. Farooq, V. Onuma, Y. Diletti, R. Windecker, S. Thuesen, L. McClean, D. Koolen, J. Whitbourn, R. |
2011-12-01
|
|
Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12 months after implantation: Insights from the ABSORB B trial
(Article)
Brugaletta, S. Gomez-Lara, J. Windecker, S. Smits, P.C. Bruyne, B. de Whitbourn, R. Meredith, I. Domburg, R.T. van Sihan, K. Winter, S. de Veldhof, S. Miquel-Hébert, K. Serruys, P.W.J.C. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Bruining, N. Farooq, V. Geuns, R-J.M. van Thuesen, L. Dudek, D. Koolen, J. Chevalier, B. McClean, D. |
2011-12-01
|
|
Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold
(Article)
Brugaletta, S. Gomez-Lara, J. Whitbourn, R. Meredith, I. Dorange, C. Veldhof, S. Rapoza, R. Ormiston, J.A. Serruys, P.W.J.C. Garcia-Garcia, H.M. Heo, J.H. Farooq, V. Geuns, R-J.M. van Chevalier, B. Windecker, S. McClean, D. Thuesen, L. |
2011-11-24
|
|
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de Novo Coronary Artery stenosis: 12-month clinical and imaging outcomes
(Article)
Serruys, P.W.J.C. Onuma, Y. Windecker, S. Whitbourn, R. Meredith, I. Dorange, C. Veldhof, S. Hebert, K.M. Sudhir, K. Garcia-Garcia, H.M. Ormiston, J.A. Dudek, D. Smits, P.C. Koolen, J. Chevalier, B. Bruyne, B. de Thuesen, L. McClean, D. Geuns, R-J.M. van |
2011-10-04
|
|
Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography
(Article)
Gomez-Lara, J. Radu, M. Whitbourn, R. Dudek, D. Smits, P.C. Regar, E.S. Veldhof, S. Rapoza, R. Ormiston, J.A. Garcia-Garcia, H.M. Serruys, P.W.J.C. Brugaletta, S. Farooq, V. Diletti, R. Onuma, Y. Windecker, S. Thuesen, L. McClean, D. Koolen, J. |
2011-09-01
|
|
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm
(Article)
Diletti, R. Onuma, Y. Chevalier, B. McClean, D. Windecker, S. Whitbourn, R. Smits, P.C. Koolen, J. Meredith, I. Li, D. Veldhof, S. Rapoza, R. Farooq, V. Garcia-Garcia, H.M. Ormiston, J.A. Serruys, P.W.J.C. Gomez-Lara, J. Brugaletta, S. Geuns, R-J.M. van Regar, E.S. Bruyne, B. de Dudek, D. Thuesen, L. |
2011-07-12
|
|
Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent
(Article)
Onuma, Y. Serruys, P.W.J.C. Windecker, S. Whitbourn, R. Meredith, I. Garcia-Garcia, H.M. Ormiston, J.A. Gomez, J. Bruyne, B. de Dudek, D. Thuesen, L. Smits, P. Chevalier, B. McClean, D. Koolen, J. |
2011-07-01
|
|
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up
(Article)
Gomez-Lara, J. Brugaletta, S. Whitbourn, R. Smits, P.C. Chevalier, B. Morel, M-A.M. Dorange, C. Veldhof, S. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Serruys, P.W.J.C. Farooq, V. Geuns, R-J.M. van Bruyne, B. de Windecker, S. McClean, D. Thuesen, L. Dudek, D. Koolen, J. |
2011-07-01
|
|
A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds
(Article)
Gomez-Lara, J. Brugaletta, S. Whitbourn, R. Windecker, S. Garcia-Garcia, H.M. Regar, E.S. Serruys, P.W.J.C. Diletti, R. Garg, S.A. Onuma, Y. Gogas, B.D. Geuns, R-J.M. van Dorange, C. Veldhof, S. Rapoza, R. |
2011-02-01
|
|
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: Six-month clinical and imaging outcomes
(Article)
Serruys, P.W.J.C. Onuma, Y. Koolen, J. Windecker, S. Whitbourn, R. Meredith, I. Dorange, C. Veldhof, S. Miquel-Hébert, K. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Bruyne, B. de Regar, E.S. Dudek, D. Thuesen, L. Smits, P.C. Chevalier, B. McClean, D. |
2010-11-30
|